What is the likely diagnosis and appropriate management for a patient with low red blood cell count, ferritin 23 ng/mL, serum iron 80 µg/dL, transferrin 308 mg/dL, total iron‑binding capacity 385 µg/dL, and iron saturation 21%?

Iron Deficiency Anemia Diagnosis

Based on your laboratory values (ferritin 23 ng/mL, iron saturation 21%, low RBC), you have iron deficiency anemia (IDA) and require both iron replacement therapy and investigation to identify the underlying cause of blood loss or malabsorption.

Diagnostic Interpretation

Your lab results clearly indicate iron deficiency anemia:

• Ferritin 23 ng/mL: Well below the diagnostic threshold of 30 ng/mL for iron deficiency 1
• Iron saturation 21%: Borderline (normal is typically >20%), but combined with low ferritin confirms diagnosis 2
• Elevated TIBC (385 µg/dL) and transferrin (308 mg/dL): Classic compensatory response to iron deficiency
• Low RBC count: Confirms anemia is present

The 2024 AGA guidelines note that ferritin <45 mg/dL in anemic patients has optimal sensitivity and specificity for IDA 3, and your ferritin of 23 clearly meets this criterion.

Required Workup to Find the Cause

You must identify why you're iron deficient, as this directly impacts mortality and quality of life. The evaluation should include:

For Premenopausal Women:

• Assess menstrual blood loss patterns (heavy or prolonged periods are responsible for most cases) 1
• If heavy menstrual bleeding is present and you're otherwise healthy, treating the bleeding source plus iron replacement is reasonable 4

For Men and Postmenopausal Women:

• Bidirectional endoscopy (upper and lower GI) is mandatory to exclude gastrointestinal bleeding or malignancy 4
• This is non-negotiable as recurrent blood loss accounts for 94% of IDA cases 4

For All Patients:

• Test for Helicobacter pylori (noninvasive testing) - common treatable cause 3, 4
• Screen for celiac disease (tissue transglutaminase antibody) - impairs iron absorption 3, 4
• Review dietary iron intake and any medications (NSAIDs, anticoagulants) 1
• Consider inflammatory bowel disease if GI symptoms present 2

Treatment Approach

First-Line: Oral Iron Supplementation

Start with oral ferrous sulfate 325 mg daily or every other day 3, 1, 4:

• Every-other-day dosing improves absorption and reduces side effects 4
• Take on empty stomach when possible; if not tolerated, take with meals (preferably with meat protein and 500 mg vitamin C) 3
• Expect gastrointestinal side effects (nausea, constipation, abdominal pain) in approximately 50% of patients 4
• Recheck labs in 2-4 weeks to assess response (hemoglobin should rise by 1-2 g/dL) 4

When to Use Intravenous Iron Instead:

Switch to IV iron if 3, 1, 4:

• Oral iron not tolerated or causes significant side effects
• No adequate response after 2-4 weeks of oral therapy
• Malabsorption conditions present (celiac disease, post-bariatric surgery, inflammatory bowel disease)
• Ongoing blood loss that cannot be immediately controlled
• Chronic inflammatory conditions (chronic kidney disease, heart failure, IBD, cancer)
• Second or third trimester of pregnancy

IV iron formulations have <1% risk of hypersensitivity reactions with newer preparations 4.

Critical Pitfalls to Avoid

• Don't assume dietary causes alone - 94% of IDA is from blood loss 4
• Don't skip GI evaluation in men or postmenopausal women - malignancy must be excluded
• Don't use daily high-dose oral iron - alternate-day dosing with moderate doses (28-50 mg elemental iron) improves compliance 5
• Don't continue oral iron indefinitely without monitoring - recheck ferritin every 6-12 months once replete 5
• Don't give iron supplementation if ferritin is normal or high - this is potentially harmful 5

Monitoring Plan

• Repeat CBC and iron studies in 2-4 weeks to confirm response
• Once anemia resolves, continue iron until ferritin >50-100 ng/mL to replenish stores
• Long-term monitoring every 6-12 months if recurrent risk factors present 5